- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06611618
Análisis de la pérdida de fuerza muscular, potencia muscular y degradación del control motor para predecir el riesgo de caídas en pacientes con osteoartritis de rodilla (PowerAGING)
Analisi Della Perdita di Forza e Potenza Muscolare e Del Degrado Del Controllo Motorio Per la Predizione Delle Cadute in Una Popolazione Affetta da Artrosi di Ginocchio
The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is:
● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population?
Participants will undergo:
- Muscle force assessment on a dynamometer
- Muscle power assessment on a dynamometer and on isntrumented stairs
- Home-based mobility monitoring
- Full lower limb MRI acquisition
- Gait assessment
Descripción general del estudio
Estado
Descripción detallada
Falls are a critical yet common event among the elderly, with huge societal and economic impact (reduced quality of life and high costs for the healthcare system). Experimental measures to quantify the residual muscle strength and power may provide useful information to predict the risk of falls in the elderly. Isometric and isokinetic muscle contractions, performed on a dynamometer or during functional tasks can be collected, together with electromyography (to assess muscle activity) and imaging data (to quantify and characterize muscular tissue).
Such data can be collected at different time points to monitor subjects over time, and to inform virtual representation of the human musculoskeletal system (digital twins) to identify possible motor control deficits. Moreover, this same information can be used to better characterize/assess elder individuals at risk of falling (e.g., subjects with knee osteoarthritis), to prevent future falls.
All subjects enrolled in the PowerAGING study will be followed up for 24 months (5 visits in total: M0, M6, M12, M18 and M24 follow-up). At each visit, a series of experimental tests to quantify muscle power and muscle force, as well as a home-based mobility assessment (via single inertial sensor worn for 5 consecutive days), will be performed. In addition, only at start and end, the subjects will undergo a full lower limb MRI and a gait assessment.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Lisa Berti, Professor
- Número de teléfono: +390516366529
- Correo electrónico: lisa.berti@ior.it
Copia de seguridad de contactos de estudio
- Nombre: Massimiliano Baleani, Engineer
- Número de teléfono: +390516366865
- Correo electrónico: massimiliano.baleani@ior.it
Ubicaciones de estudio
-
-
-
Bologna, Italia, 40136
- Reclutamiento
- IRCCS Istituto Ortopedico Rizzoli
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age between 65 and 80 years
- Kellgren score II e III
- No history of falls in the last 12 months
Exclusion Criteria:
- Any musculoskeletal, neurological, rheumatic or tumoral diseases
- Dementia
- Diabetes
- Inguinal or abdominal hernia
- Severe Hypertension (Level 3)
- Severe Cardio-pulmonary insufficiency
- Diagnosis of Osteonecrosis in the lower limb joints
- Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
- Previous interventions or traumas to the joints of the lower limb
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Knee Osteoarthritis
Elderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment). All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit. |
Isokinetic dynamometry test Stair ascent/descent on instrumented stairs Isometric dynamometry (Maximal Voluntary Isometric Contraction) Mobility monitoring with wearable sensors Full lower limb MRI Motion capture, surface EMG and gorund reaction force data |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Maximal muscle force
Periodo de tiempo: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Maximal Isometric muscle force from dynamometry test |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle power
Periodo de tiempo: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Assessed on the dynamometer and during dynamic tasks |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle activations
Periodo de tiempo: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
From surface EMG data collected on the dynamometer and during dynamic tasks (gait assessment and stair ascent/descent) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Digital Mobility Outcomes
Periodo de tiempo: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Qualitative and quantiative measures of real-world mobility (e.g., gait speed, stride length) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Musculoskeletal model predictions
Periodo de tiempo: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Estimates of muscle force and knee joint contact forces |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle volumes
Periodo de tiempo: From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Estimation of muscle volumes (cm3) |
From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lisa Berti, Professor, IRCCS Istituto Ortopedico Rizzoli
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CE-AVEC 204/2024/Sper/IOR
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .